A prospective-randomized trial using Octreotide for prevention of complications following pancreaticoduodenectomy

Revista Espanola de Enfermedades Digestivas

Volumn 90, Issue 10, 1998, Pages 691-694

  Briceno Delgado F J ^a,b   Lopez Cillero P ^a   Rufian Pena S ^a   Solorzano Peck G ^a   Mino Fugarolas G ^a   Pera Madrazo, C ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Dolores Ibarruri   (Spain)

Author keywords

Octreotide; Pancreatic fistula; Pancreaticoduodenectomy

Indexed keywords

AMYLASE; OCTREOTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MORBIDITY; MORTALITY; PANCREAS FISTULA; PANCREAS SECRETION; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031721967     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, et al. Hypothalamic polypeptide that inhibits the secretion of inmuoreactive pituitary growth hormone. Science 1973;179:77-9.
2. Bauer W, Briner U, Doepfner W, Haller R, Hugnenin R, Marbach P, et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982;31:1133.
3. Cai RZ, Szoke B, Lu R, et al. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Proc Natl Acad Sci. USA 1986;83:1896-900.
4. Köhler E, Beglinger C, Dettwiler S, et al. Effect of a new somatostatin analogue on pancreatic function in healthy volunteers. Pancreas 1986;1:154-9.
5. Grimaldi C, Lapalus F, Delmont J, et al. Effect of somatostatin analog in healthy volunteers. Gastroenterology 1987;92:1737.
6. Trede M, Schwall G. The complications of pancreatectomy. Ann Surg 1988;207:39-47.
7. Büchler M, Friess H, Klemper I, et al. The role of somatostatin analogue octreotide in the prevention of postoperative complications following pancreatic resection. The results of a multicenter controlled trial. Am J Surg 1992;163:125-31.
8. Prinz RA, Pickleman J, Hoffman JP. Treatment of pancreatic cutaneous fistula with a somatostatin analogue. Am J Surg 1988;155:36-42.
9. Peters JH, Carey LC. Historical review of pancreaticoduodenectomy. Am J Surg 1991;161:219-25.
10. Whipple AO. Observations on radical surgery for lesions of the pancreas. Surg Gynecol Obstet 1986;82:623-31.
11. Neptolemos JP, Talbot IC, Carr-Locke DL, et al. Treatment and outcome in 52 consecutive cases of ampullry carcinoma. Br J Surg 1987;74:957-61.
12. Crist D, Sitzmann J, Cameron J. Improved hospital morbidity, mortality and survival after Whipple procedure. Ann Surg 1987;206:358-65.
13. Pera C, Padillo F, Solórzano G, et al. Resultados de la DPC en patología periampular. Rev Esp Enferm Dig 1994;86:661-4.
14. Klempa. Schweden U, Usadel KH, Verhütung von postoperativen pankreatisctischen komplicationen nach Duodenopankretektomie durch somatostatin. Chirurg 1979;50:427-32.
15. Williams S, Woltering E, O'Dorisio T, et al. Effect of Octreotide Acetate on pancreatic exocrine function. Am J Surg 1989;157:459-62.